| - Industry | - Sector | Mr. Jae Won Park CEO | KRX SM Exchange | KR7303810006 ISIN |
| South Korea Country | - Employees | - Last Dividend | 7 Aug 2025 Last Split | - IPO Date |
Dongkook Life Science Co., Ltd. is a leading name within the pharmaceutical landscape, specializing in the research, development, manufacturing, and distribution of a diverse range of healthcare products. With its headquarters located in South Korea, the company is dedicated to enhancing health and well-being, providing innovative solutions across various sectors including pharmaceuticals, medical devices, and health supplements. Dongkook Life Science has successfully carved a niche for itself by adopting a comprehensive approach to healthcare, catering to hospitals, clinics, pharmacies, and individual consumers. Its expansive operations not only dominate the domestic market but also reach into international arenas, showcasing its pivotal contributions to global health improvement. The company’s strategic investments in cutting-edge technologies and active research initiatives highlight its unwavering commitment to advancing therapeutic possibilities and ensuring accessible healthcare solutions.
Dongkook Life Science produces a variety of pharmaceutical products including prescription medications and over-the-counter drugs. These pharmaceuticals are designed to treat various health conditions, ensuring effective relief and management options available for both healthcare professionals and patients.
The company offers an assortment of medical devices aimed at enhancing patient care and treatment outcomes. These devices include diagnostic tools, surgical instruments, and monitoring equipment, all engineered to meet stringent regulatory standards while focusing on safety and efficacy.
In addition to pharmaceuticals and medical devices, Dongkook Life Science produces a range of health supplements formulated to support overall wellness and preventative healthcare. These supplements are crafted using high-quality ingredients, providing consumers with options for boosting immunity, energy levels, and overall health.
The company is deeply invested in research and development, prioritizing innovation to introduce new therapeutic solutions. This encompasses various studies aimed at discovering new drugs, improving existing formulations, and expanding the applications of current healthcare products.
Dongkook Life Science successfully operates a robust distribution network that ensures its products reach diverse markets worldwide. By engaging in strategic partnerships and continuous market analysis, the company guarantees efficient distribution, thereby improving accessibility to their innovative healthcare products.